<DOC>
	<DOCNO>NCT01877109</DOCNO>
	<brief_summary>The purpose study establish model predict treatment outcome risk treatment-related morbidity patient lymphoma .</brief_summary>
	<brief_title>Samsung Medical Center-Lymphoma Cohort Study-II</brief_title>
	<detailed_description>Although cure rate lymphoma increase due development newer effective drug , substantial portion patient still suffer relapse . Furthermore , treatment-related morbidity another factor make treatment outcome worse patient lymphoma , especially elderly patient . Thus , study go assess factor may affect treatment outcome risk treatment-related morbidity . 1.Biologic factor associate aggressiveness lymphoma - molecular marker serum , cytogenetic marker 2.Factors associate risk treatment-related morbidity - comorbidity , nutrition status , performance status , quality life diagnosis</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Patients diagnose lymphoma Over 19 year old Patients agree enrollment study Informed consent sample â€¢Patients want join study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>Prognosis</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Quality life</keyword>
</DOC>